
Paclitaxel-Actavis 100 mg vial is a prescription chemotherapy product. It contains paclitaxel, an antineoplastic medicine from the taxane family. Paclitaxel acts on microtubules, structures that cells need to divide, which helps slow or stop the growth of sensitive cancer cells. It is not an oral tablet and must not be self-administered at home.
Taxol is a well-known paclitaxel brand name, so patients may use the words Taxol, paclitaxel, and paclitaxel vial when searching. However, Paclitaxel-Actavis, other conventional paclitaxel brands, and albumin-bound paclitaxel are not automatically interchangeable because formulation, dilution, preparation, and administration may differ.
| FeatureDetails | |
| Brand | Paclitaxel-Actavis |
| Active ingredient | Paclitaxel |
| Strength discussed | 100 mg vial |
| Form | Concentrate/vial for intravenous infusion |
| Main use | Chemotherapy for selected cancers |
You can review the verified product listing for Paclitaxel-Actavis 100 mg vial on Vezeeta.
Paclitaxel is used in specialist cancer protocols. Recognized uses include ovarian cancer, breast cancer, non-small cell lung cancer, and AIDS-related Kaposi’s sarcoma. It may be used alone or with other anticancer medicines depending on cancer type, stage, previous treatment, blood counts, liver function, and treatment goal.
Paclitaxel may be part of a breast cancer treatment plan, especially in adjuvant or metastatic settings. For general background, you can read Vezeeta’s breast cancer guide. If you need specialist assessment, you can also book an oncologist in Egypt.
Paclitaxel is often searched with carboplatin because this combination is used in some protocols, especially for ovarian cancer and some lung cancer regimens. The exact combination and sequence must be chosen by the oncology team.
Paclitaxel dose is calculated by the oncology team, usually by body surface area in mg/m². Common conventional paclitaxel schedules include 135–175 mg/m² by intravenous infusion in selected protocols, often every 3 weeks, but schedules vary widely. Dose delay or reduction may be needed if blood counts are low, liver tests are abnormal, neuropathy is severe, or other toxicity occurs.
The vial is diluted and infused by trained healthcare professionals in a chemotherapy unit. Premedication is commonly given before conventional paclitaxel to reduce the risk of severe allergic reactions. This may include a corticosteroid, an antihistamine, and an H2 blocker according to the center’s protocol.
Paclitaxel is given into a vein, so food does not control its absorption like oral medicines. Follow your chemotherapy unit’s instructions about eating before the session, nausea prevention, fluids, and fasting if another procedure is planned.
If you miss a chemotherapy appointment, contact the oncology clinic immediately. Do not try to compensate by taking another medicine or changing the next appointment yourself.
Paclitaxel starts acting on dividing cells after infusion, but tumor response is not usually felt immediately. Doctors assess benefit over treatment cycles using symptoms, examination, imaging, tumor markers when relevant, and blood tests. The drug level may fall over hours, while effects on cancer cells and blood counts may last much longer.
Common paclitaxel side effects may include hair loss, tiredness, nausea, vomiting, diarrhea, mouth soreness, muscle or joint pain, numbness or tingling in the hands and feet, low white blood cells, anemia, low platelets, infection risk, changes in liver tests, and infusion-site irritation.
Bone marrow suppression is an important risk. This means the body may temporarily make fewer infection-fighting cells, red blood cells, or platelets. Regular blood tests before and during treatment are essential.
Seek urgent medical help if you develop fever, chills, shortness of breath, wheezing, chest pain, facial or throat swelling, severe rash, fainting, uncontrolled vomiting or diarrhea, black stools, unusual bleeding, severe weakness, confusion, painful swelling at the injection site, or rapidly worsening numbness or weakness.
Paclitaxel should not be used in patients with severe hypersensitivity to paclitaxel or formulation ingredients such as polyoxyl castor oil in conventional products. It is also avoided when baseline neutrophil counts are too low. Treatment must be supervised by clinicians experienced in chemotherapy, with facilities available to manage allergic reactions and complications.
Tell your doctor if you have liver disease, heart rhythm problems, previous severe neuropathy, active infection, recent radiotherapy, or previous allergic reactions to chemotherapy. Some conventional paclitaxel formulations contain alcohol, so temporary drowsiness or reduced alertness may occur after infusion.
Paclitaxel is metabolized mainly through CYP2C8 and CYP3A4 pathways. Medicines that strongly inhibit or induce these pathways may change paclitaxel exposure. Examples that need review include certain antifungals, macrolide antibiotics, HIV protease inhibitors, anticonvulsants such as phenytoin or phenobarbital, rifampin, and some heart medicines.
When paclitaxel is combined with platinum chemotherapy, anthracyclines, or other anticancer medicines, sequence and timing may matter. Always give the oncology team a full list of prescription medicines, supplements, herbal products, and over-the-counter drugs.
Paclitaxel can harm a developing fetus and is generally avoided during pregnancy unless the specialist decides that potential benefit justifies the risk. Effective contraception is usually required during treatment. Patients planning pregnancy or fertility preservation should discuss this before chemotherapy starts.
Breastfeeding is not recommended during paclitaxel treatment because of potential risk to the infant. Ask the oncology team when breastfeeding could be safely resumed after the final dose.
Paclitaxel is not taken daily like routine tablets. It is administered in cycles, with rest periods to allow recovery. Long-term use depends on cancer response, tolerance, treatment goal, neuropathy, blood counts, liver function, and the overall plan. Do not continue, stop, or delay cycles without medical instruction.
Alternatives depend on cancer type and treatment intent. They may include other paclitaxel brands, albumin-bound paclitaxel, docetaxel, platinum agents such as carboplatin or cisplatin, anthracyclines, gemcitabine, targeted therapy, immunotherapy, hormonal therapy, radiation, or surgery. Substitution is never automatic because formulations and protocols differ.
The price of paclitaxel, Taxol 100, or Paclitaxel-Actavis in Egypt may change depending on availability, manufacturer, pharmacy, import status, and hospital supply. For current availability and ordering information, check Paclitaxel-Actavis on Vezeeta or ask your treating center. Do not choose a chemotherapy brand only by price without oncologist approval.
Paclitaxel is a taxane chemotherapy medicine used to treat selected cancers by interfering with cell division.
It may be used in treatment protocols for breast cancer, ovarian cancer, non-small cell lung cancer, and Kaposi’s sarcoma.
Both contain paclitaxel, but brand, formulation, excipients, and handling requirements may differ. Do not switch without medical approval.
It is diluted and given as an intravenous infusion by trained staff in a chemotherapy unit, often with premedication.
It stabilizes microtubules needed for cell division, making it harder for sensitive cancer cells to multiply.
They attack cancer cells through different mechanisms and are used together in some protocols to improve anticancer effect.
The sequence follows established protocols and may affect safety and tolerability. The oncology unit sets the order.
The dose is commonly based on body surface area, cancer type, regimen, blood counts, liver function, and previous side effects.
Hair loss, low blood counts, infection risk, nausea, muscle or joint pain, fatigue, and peripheral neuropathy are common.
The measured drug level falls over hours after conventional infusion, but effects on blood cells and nerves may last days to weeks.
Cost varies by brand, dose, and availability. Check current local listings and confirm suitability with your oncologist.
Paclitaxel can be an important part of breast cancer treatment, but cure depends on cancer type, stage, biology, surgery, radiotherapy, and the full plan.
The information in this article is provided for general health education and does not replace medical advice from a doctor or pharmacist. Do not start, stop, or change the dose of any medication without consulting a qualified healthcare professional.
استشاري علاج الاورام وامراض الدم و الطب النووي طب الازهر
استشاري و مدرس علاج الأورام والكشف المبكر للاورام
إستشاري و دكتوراة في علاج الأورام و الطب النووي جامعة القاهرة القصر العيني
استشاري علاج الاورام وامراض الدم و الطب النووي طب الازهر
استشاري و مدرس علاج الأورام والكشف المبكر للاورام
إستشاري و دكتوراة في علاج الأورام و الطب النووي جامعة القاهرة القصر العيني